Lanean...

Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7

Clinical trials have demonstrated that an increased number of effector cells, especially tumor-specific T cells, is positively linked with patients’ prognosis. Although the discovery of checkpoint inhibitors (CPIs) has led to encouraging progress in cancer immunotherapy, the lack of either T cells o...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMB Rep
Egile Nagusiak: Kim, Ji-Hae, Lee, Kun-Joo, Lee, Seung-Woo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Society for Biochemistry and Molecular Biology 2021
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851446/
https://ncbi.nlm.nih.gov/pubmed/33407991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2021.54.1.257
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!